$1.75
0.04[2.34%]
At close: Apr 26
$1.75
0[0.00%]
After Hours: 4:20PM EDT
PMV Pharma
(NASDAQ:PMVP)PMV Pharma Stock (NASDAQ:PMVP), Analyst Ratings, Price Targets, Predictions
PMV Pharmaceuticals Inc has a consensus price target of $18.83, established from looking at the 17 latest analyst ratings. The last 3 analyst ratings were released from Jefferies, HC Wainwright & Co., and Ladenburg Thalmann on April 12, 2024, March 7, 2024, and December 27, 2023. With an average price target of $5.67 between Jefferies, HC Wainwright & Co., and Ladenburg Thalmann, there's an implied 223.81% upside for PMV Pharmaceuticals Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
Jefferies
HC Wainwright & Co.
Ladenburg Thalmann
Oppenheimer
Goldman Sachs
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for PMV Pharma
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 04/12/2024 | PMVP | Buy Now | PMV Pharma | $1.75 | 185.71% | Jefferies | Kambiz Yazdi | → $5 | Initiates | → Buy | Get Alert |
| 03/07/2024 | PMVP | Buy Now | PMV Pharma | $1.75 | 185.71% | HC Wainwright & Co. | Robert Burns | → $5 | Reiterates | Buy → Buy | Get Alert |
| 12/27/2023 | PMVP | Buy Now | PMV Pharma | $1.75 | 300% | Ladenburg Thalmann | Aydin Huseynov | → $7 | Initiates | → Buy | Get Alert |
| 10/16/2023 | PMVP | Buy Now | PMV Pharma | $1.75 | 185.71% | HC Wainwright & Co. | Robert Burns | $29 → $5 | Maintains | Buy | Get Alert |
| 08/11/2023 | PMVP | Buy Now | PMV Pharma | $1.75 | 1557.14% | HC Wainwright & Co. | Robert Burns | $35 → $29 | Maintains | Buy | Get Alert |
| 05/17/2023 | PMVP | Buy Now | PMV Pharma | $1.75 | 1900% | HC Wainwright & Co. | Robert Burns | → $35 | Reiterates | Buy → Buy | Get Alert |
| 05/11/2023 | PMVP | Buy Now | PMV Pharma | $1.75 | 757.14% | Oppenheimer | Jeff Jones | → $15 | Reiterates | Outperform → Outperform | Get Alert |
| 03/20/2023 | PMVP | Buy Now | PMV Pharma | $1.75 | 1900% | HC Wainwright & Co. | Robert Burns | $36 → $35 | Maintains | Buy | Get Alert |
| 03/02/2023 | PMVP | Buy Now | PMV Pharma | $1.75 | 757.14% | Oppenheimer | Jeff Jones | $28 → $15 | Maintains | Outperform | Get Alert |
| 11/17/2022 | PMVP | Buy Now | PMV Pharma | $1.75 | 1957.14% | HC Wainwright & Co. | Robert Burns | $63 → $36 | Maintains | Buy | Get Alert |
| 06/09/2022 | PMVP | Buy Now | PMV Pharma | $1.75 | 1785.71% | Oppenheimer | Jeff Jones | $30 → $33 | Maintains | Outperform | Get Alert |
| 05/24/2022 | PMVP | Buy Now | PMV Pharma | $1.75 | 1328.57% | Goldman Sachs | Paul Choi | $43 → $25 | Maintains | Buy | Get Alert |
| 03/02/2022 | PMVP | Buy Now | PMV Pharma | $1.75 | — | Oppenheimer | Jeff Jones | — | Upgrade | Perform → Outperform | Get Alert |
| 09/22/2021 | PMVP | Buy Now | PMV Pharmaceuticals | $1.75 | 2357.14% | Goldman Sachs | Paul Choi | — | Upgrade | Neutral → Buy | Get Alert |
| 08/19/2021 | PMVP | Buy Now | PMV Pharmaceuticals | $1.75 | — | Oppenheimer | Jeff Jones | — | Initiates | → Perform | Get Alert |
| 08/02/2021 | PMVP | Buy Now | PMV Pharmaceuticals | $1.75 | 3100% | Guggenheim | Charles Zhou | — | Initiates | → Buy | Get Alert |
| 07/29/2021 | PMVP | Buy Now | PMV Pharmaceuticals | $1.75 | 3500% | HC Wainwright & Co. | Robert Burns | — | Initiates | → Buy | Get Alert |
FAQ
What is the target price for PMV Pharma (PMVP)?
The latest price target for PMV Pharma (NASDAQ: PMVP) was reported by Jefferies on April 12, 2024. The analyst firm set a price target for $5.00 expecting PMVP to rise to within 12 months (a possible 185.71% upside). 7 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for PMV Pharma (PMVP)?
The latest analyst rating for PMV Pharma (NASDAQ: PMVP) was provided by Jefferies, and PMV Pharma initiated their buy rating.
When was the last upgrade for PMV Pharma (PMVP)?
The last upgrade for PMV Pharmaceuticals Inc happened on March 2, 2022 when Oppenheimer raised their price target to N/A. Oppenheimer previously had a perform for PMV Pharmaceuticals Inc.
When was the last downgrade for PMV Pharma (PMVP)?
There is no last downgrade for PMV Pharma.
When is the next analyst rating going to be posted or updated for PMV Pharma (PMVP)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of PMV Pharma, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for PMV Pharma was filed on April 12, 2024 so you should expect the next rating to be made available sometime around April 12, 2025.
Is the Analyst Rating PMV Pharma (PMVP) correct?
While ratings are subjective and will change, the latest PMV Pharma (PMVP) rating was a initiated with a price target of $0.00 to $5.00. The current price PMV Pharma (PMVP) is trading at is $1.75, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.